Literature DB >> 17983549

[Polymyositis and interstitial lung disease with a favorable response to corticosteroids and methotrexate].

Nieves Hoyos1, Alvaro Casanova, Silvia Sánchez, Claudia Valenzuela, Asunción García, Rosa María Girón.   

Abstract

Polymyositis is a rare collagen disease that can involve the lungs. Between 5% and 30% of patients with polymyositis present interstitial lung disease at diagnosis or during the course of disease. Onset is usually insidious and involves dyspnea and nonproductive cough. Several histopathological findings are associated with polymyositis and the most common is nonspecific interstitial pneumonia. The prognosis of interstitial lung disease associated with polymyositis is better than that of idiopathic pulmonary fibrosis, since most patients respond to treatment with corticosteroids and immunosuppressants. We report the case of a 60-year-old woman with dyspnea and muscle weakness who was diagnosed with polymyositis and interstitial lung disease (radiography indicated possible nonspecific interstitial pneumonia). The patient responded well to prednisone and methotrexate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17983549     DOI: 10.1016/s1579-2129(07)60142-6

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  1 in total

1.  [Organizing pneumonia revealing a polymyositis].

Authors:  Ahmed Ben Saad; Samah Joobeur; Naceur Rouetbi; Saousen Cheikh Mhamed; Néji Skhiri; Hathami Mribah; Ali El Kamel
Journal:  Pan Afr Med J       Date:  2014-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.